[The treatment of atypical manias with finlepsin-retard].
The article presents results of clinical trial of finlepsine-retard. Objectivized parameters characterizing the time course of psychopathologic symptoms were studied in certain concentrations of finlepsine and beta-endrofin in blood serum. Atypical maniac states do not easily respond to therapies but finlepsine-retard gives the modern psychopharmacotherapy a new horizon.